Clinical outcomes of keratitis

被引:64
|
作者
Green, Matthew D.
Apel, Andrew J. G.
Naduvilath, Thomas
Stapleton, Fiona J.
机构
[1] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia
[2] Gold Coast Hosp, Southport, Qld, Australia
[3] Univ New S Wales, Vis CRC, Sydney, NSW, Australia
[4] Univ New S Wales, Eye Res Inst, Sydney, NSW, Australia
[5] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia
来源
关键词
cephalosporin; contact lens; pseudomonas; resistance;
D O I
10.1111/j.1442-9071.2007.01511.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objection: To analyse the patient, clinical and microbiological variables associated with poor outcomes from keratitis in patients presenting to a major public hospital in Australia. Methods: A retrospective audit of the records of all patients who had a corneal scraping in 5 years at Princess Alexandra Hospital (Brisbane, Australia) was carried out. The outcome of a patient's episode of keratitis was classified as poor if they had final visual acuity of 6/60 or worse; had vision loss during treatment; or a complication of keratitis; or needed surgical intervention. Results: A final outcome was established in 207 cases during the 5-year period. Final vision of 6/12 or better was found in 48% (100) of cases while a poor outcome was seen in 28% (58). Linear regression showed poor outcomes were directly associated with age (P < 0.001) and disease severity (P < 0.001). Univariate analysis indicated that poor outcomes were more likely in patients who had had prior ocular surgery (P = 0.005) or ocular surface disease (P = 0.01) and were also associated with presenting visual acuity of worse than 6/60 (P < 0.001) and isolation of Streptococcus pneumoniae (P = 0.002). While patients with traumatic keratitis, contact lens-related keratitis or negative corneal cultures (P = 0.009) were more likely to have good outcomes. Multivariate analysis showed that the relative risk of a patient having a poor outcome was 4.3x (CI 2.0-9.5) if they had severe keratitis, 4.1x (CI 1.8-9.5) if they had keratitis related to ocular surface disease and 3.8x (CI 1.8-8.3) if they were over 50 years old. Conclusions: An outcome of poor vision, vision loss during treatment, surgical intervention or complication of keratitis is more likely in patients with severe keratitis, keratitis related to prior ocular surface disease or older age.
引用
收藏
页码:421 / 426
页数:6
相关论文
共 50 条
  • [41] Clinical Characteristics and Outcomes of Rare Fungal Keratitis Caused by Verticillium dahliae
    Qing Huang
    Wenlu Zhang
    Yu Sun
    Xiaofeng Li
    Xiaoyu Zhang
    Xiuhai Lu
    Xiaolin Qi
    Mycopathologia, 2022, 187 : 95 - 102
  • [42] Clinical variant of herpetic keratitis: Archipelago keratitis
    Levy, N.
    Carbonnel, E.
    Bertrand, E.
    Mairot, K.
    Gonzalvez, M.
    Denis, D.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (04): : 609 - 610
  • [43] Influence of Acanthamoeba Genotype on Clinical Course and Outcomes for Patients with Acanthamoeba Keratitis in Spain
    Arnalich-Montiel, Francisco
    Lumbreras-Fernandez, Blanca
    Martin-Navarro, Carmen M.
    Valladares, Basilio
    Lopez-Velez, Rogelio
    Morcillo-Laiz, Rafael
    Lorenzo-Morales, Jacob
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (04) : 1213 - 1216
  • [44] Clinical Characteristics, Histopathology, and Treatment Outcomes of Pythium Keratitis: A Retrospective Cohort Study
    Puangsricharern, Vilavun
    Chotikkakamthorn, Patraramon
    Tulvatana, Wasee
    Kittipibul, Thanachaporn
    Chantaren, Patchima
    Reinprayoon, Usanee
    Kasetsuwan, Ngamjit
    Satitpitakul, Vannarut
    Worasilchai, Navaporn
    Chindamporn, Ariya
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 1691 - 1701
  • [45] Clinical outcomes and prognostic factors associated with Acanthamoeba keratitis treated with pentamidine isethionate
    Huang, Jane
    Ozaki, Hiroaki
    Umeda, Naoyasu
    Fuchigami, Aki
    Kozawa, Masahiko
    Uchio, Eiichi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [46] Association Between Cytotoxic and Invasive Pseudomonas aeruginosa and Clinical Outcomes in Bacterial Keratitis
    Borkar, Durga S.
    Fleiszig, Suzanne M. J.
    Leong, Chelsia
    Lalitha, Prajna
    Srinivasan, Muthiah
    Ghanekar, Avanti A.
    Tam, Connie
    Li, Wing Y.
    Zegans, Michael E.
    McLeod, Stephen D.
    Lietman, Thomas M.
    Acharya, Nisha R.
    JAMA OPHTHALMOLOGY, 2013, 131 (02) : 147 - 153
  • [47] Aspergillus keratitis: Molecular identification, antifungal susceptibility, clinical outcomes and virulence factors
    Gajjar, D. U.
    Pal, A. K.
    Ghodadra, B. K.
    Vasavada, A. R.
    MYCOSES, 2012, 55 : 81 - 81
  • [48] Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes
    Durrani, Asad F.
    Faith, Samuel C.
    Kowalski, Regis P.
    Yu, Marco
    Romanowski, Eric
    Shanks, Robert
    Dhaliwal, Deepinder
    Jhanji, Vishal
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 197 : 17 - 22
  • [49] Clinical Features and Treatment Outcomes of Carbapenem-Resistant Pseudomonas aeruginosa Keratitis
    Tribin, Felipe Echeverri
    Lieux, Caroline
    Maestre-Mesa, Jorge
    Durkee, Heather
    Krishna, Katherine
    Chou, Brandon
    Neag, Emily
    Tothova, Jana D'Amato
    Martinez, Jaime D.
    Flynn, Harry W.
    Parel, Jean Marie
    Miller, Darlene
    Amescua, Guillermo
    JAMA OPHTHALMOLOGY, 2024, 142 (05) : 407 - 415
  • [50] Association between In Vitro Susceptibility to Natamycin and Voriconazole and Clinical Outcomes in Fungal Keratitis
    Sun, Catherine Q.
    Lalitha, Prajna
    Prajna, N. Venkatesh
    Karpagam, Rajarathinam
    Geetha, Manoharan
    O'Brien, Kieran S.
    Oldenburg, Catherine E.
    Ray, Kathryn J.
    McLeod, Stephen D.
    Acharya, Nisha R.
    Lietman, Thomas M.
    OPHTHALMOLOGY, 2014, 121 (08) : 1495 - +